1 김상정, "소아 백혈병 환자의 동종 조혈모세포이식 전처치로서 전신방사선 조사 포함군과 비포함군의 비교" 대한소아과학회 53 (53): 538-547, 2010
2 Tracey J, "Transplantation conditioning regimens and outcomes after allogeneic hematopoietic cell transplantation in children and adolescents with acute lymphoblastic leukemia" 19 : 255-259, 2013
3 Chessells JM, "The management of high-risk lymphoblastic leukaemia in children" 108 : 204-216, 2000
4 Sanders JE, "The impact of marrow transplant preparative regimens on subsequent growth and development. The Seattle Marrow Transplant Team" 28 : 244-249, 1991
5 Santos GW, "The development of busulfan/cyclophosphamide preparative regimens" 20 (20): 12-16, 1993
6 Mori T, "Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia" 87 : 349-353, 2012
7 Bunin N, "Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study" 32 : 543-548, 2003
8 Santos GW, "Marrow transplantation in the busulfan-treated rat: preclinical model of aplastic anemia" 53 : 1781-1785, 1974
9 Bhatia S, "Malignant neoplasms following bone marrow transplantation" 87 : 3633-3639, 1996
10 Gaynon PS, "Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report" 24 : 285-297, 2010
1 김상정, "소아 백혈병 환자의 동종 조혈모세포이식 전처치로서 전신방사선 조사 포함군과 비포함군의 비교" 대한소아과학회 53 (53): 538-547, 2010
2 Tracey J, "Transplantation conditioning regimens and outcomes after allogeneic hematopoietic cell transplantation in children and adolescents with acute lymphoblastic leukemia" 19 : 255-259, 2013
3 Chessells JM, "The management of high-risk lymphoblastic leukaemia in children" 108 : 204-216, 2000
4 Sanders JE, "The impact of marrow transplant preparative regimens on subsequent growth and development. The Seattle Marrow Transplant Team" 28 : 244-249, 1991
5 Santos GW, "The development of busulfan/cyclophosphamide preparative regimens" 20 (20): 12-16, 1993
6 Mori T, "Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia" 87 : 349-353, 2012
7 Bunin N, "Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study" 32 : 543-548, 2003
8 Santos GW, "Marrow transplantation in the busulfan-treated rat: preclinical model of aplastic anemia" 53 : 1781-1785, 1974
9 Bhatia S, "Malignant neoplasms following bone marrow transplantation" 87 : 3633-3639, 1996
10 Gaynon PS, "Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report" 24 : 285-297, 2010
11 Locatelli F, "Late effects in children after bone marrow transplantation: a review" 78 : 319-328, 1993
12 Granados E, "Hematopoietic cell transplantation in acute lymphoblastic leukemia: better long term event-free survival with conditioning regimens containing total body irradiation" 85 : 1060-1067, 2000
13 Cohen A, "Growth in patients after allogeneic bone marrow transplant for hematological diseases in childhood" 15 : 343-348, 1995
14 Shankar SM, "Growth in children undergoing bone marrow transplantation after busulfan and cyclophosphamide conditioning" 18 : 362-366, 1996
15 Sanders JE, "Growth and development after hematopoietic cell transplant in children" 41 : 223-227, 2008
16 Legault L, "Endocrine complications of bone marrow transplantation in children" 3 : 60-66, 1999
17 Jongmoo Park, "Effects of total body irradiation-based conditioning on allogeneic stem cell transplantation for pediatric acute leukemia: a single-institution study" 대한방사선종양학회 32 (32): 198-207, 2014
18 Davies SM, "Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia" 18 : 340-347, 2000
19 Shulman HM, "Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients" 69 : 204-217, 1980
20 Ciurea SO, "Busulfan in hematopoietic stem cell transplantation" 15 : 523-536, 2009
21 Thomas ED, "Bone marrow transplantation in hematologic malignancies" 22 : 77-91, 1987
22 Wolden SL, "American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for the performance of total body irradiation (TBI)" 36 : 97-101, 2013
23 Hunger SP, "Acute lymphoblastic leukemia in children" 373 : 1541-1552, 2015
24 Ringdén O, "A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group" 83 : 2723-2730, 1994
25 Przepiorka D, "1994 Consensus Conference on Acute GVHD Grading" 15 : 825-828, 1995